The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes
Abstract
BACKGROUND: An effective prophylactic vaccine would help control the spread of genital herpes. METHODS: We conducted two double-blind, randomized trials of a herpes simplex virus type 2 (HSV-2) glycoprotein-D-subunit vaccine with alum and 3-O-deacylated-monophosphoryl lipid A in subjects whose regular sexual partners had a history of genital herpes. In Study 1, subjects were seronegative for herpes simplex virus type 1 (HSV-1) and HSV-2; in Study 2, subjects were of any HSV serologic status. At months 0, 1, and 6, subjects received either vaccine or a control injection and were evaluated for 19 months. The primary end point was the occurrence of genital herpes disease in all subjects in Study 1 and in HSV-2-seronegative female subjects in Study 2. RESULTS: A total of 847 subjects who were seronegative for both HSV-1 and HSV-2 (268 of them women, in Study 1) and 1867 subjects who were seronegative for HSV-2 (710 of them women, in Study 2) underwent randomization and received injections. Vaccination was well tolerated and elicited humoral and cellular responses. Overall, the efficacy of the vaccine was 38 percent in Study 1 (95 percent confidence interval, -18 to 68 percent; 15 cases occurred in the vaccine group and 24 in the control group), and efficacy in female subjects was 42 percent in Study 2 (95 percent confidence interval, -31 to 74 percent; 9 cases occurred in the vaccine group and 16 in the control group). In both studies, further analysis showed that the vaccine was efficacious in women who were seronegative for both HSV-1 and HSV-2: efficacy in Study 1 was 73 percent (95 percent confidence interval, 19 to 91 percent; P=0.01), and efficacy in Study 2 was 74 percent (95 percent confidence interval, 9 to 93 percent; P=0.02). It was not efficacious in women who were seropositive for HSV-1 and seronegative for HSV-2 at base line or in men. CONCLUSIONS: These studies suggest that the glycoprotein D vaccine has efficacy against genital herpes in women who are seronegative for both HSV-1 and HSV-2 at base line but not in those who are seropositive for HSV-1 and seronegative for HSV-2. It had no efficacy in men, regardless of their HSV serologic status.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Herpes Simplex Virus Type 2 in the United States, 1976 to 1994
Fleming, D. T., McQuillan, G. M., Johnson, R. E., Nahmias, A. J., Aral, S. O., Lee, F. K., & St. Louis, M. E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710163371601 · Cited by 1,189
A Gender Gap in Autoimmunity: Task Force on Gender, Multiple Sclerosis and Autoimmunity
Whitacre, C. C., Reingold, S. C., O'Looney, P. A., Blankenhorn, E., Brinley, F., Collier, E., Duquette, P., Fox, H., Giesser, B., Gilmore, W., et al. (1999) · Science · doi:10.1126/science.283.5406.1277 · Cited by 851
Infections with Herpes Simplex Viruses
Corey, L., & Spear, P. G. (1986) · New England Journal of Medicine · doi:10.1056/nejm198603133141105 · Cited by 778
A Prospective Study of New Infections with Herpes Simplex Virus Type 1 and Type 2
Langenberg, A. G. M., Corey, L., Ashley, R. L., Leong, W. P., & Straus, S. E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911043411904 · Cited by 510
Corey, L., Langenberg, A. G. M., Ashley, R., Sekulovich, R. E., Izu, A. E., Douglas, Jr., Handsfield, H. H., Warren, T., Marr, L., Tyring, S., et al. (1999) · JAMA · doi:10.1001/jama.282.4.331 · Cited by 490
Self-citationInfections with Herpes Simplex Viruses
Corey, L., & Spear, P. G. (1986) · New England Journal of Medicine · doi:10.1056/nejm198603203141205 · Cited by 379
Underdiagnosis of Genital Herpes by Current Clinical and Viral-Isolation Procedures
Koutsky, L. A., Stevens, C. E., Holmes, K. K., Ashley, R. L., Kiviat, N. B., Critchlow, C. W., & Corey, L. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206043262305 · Cited by 286
Su, Z., & Stevenson, M. M. (2000) · Infection and Immunity · doi:10.1128/iai.68.8.4399-4406.2000 · Cited by 260
Genital Herpes: Review of the Epidemic and Potential Use of Type-Specific Serology
Ashley, R. L., & Wald, A. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.1.1 · Cited by 222
Prospects for Control of Herpes Simplex Virus Disease through Immunization
Stanberry, L. R., Cunningham, A. L., Mindel, A., Scott, L. L., Spruance, S. L., Aoki, F. Y., & Lacey, C. J. (2000) · Clinical Infectious Diseases · doi:10.1086/313687 · Cited by 200
Self-citationSimmons, A., & Nash, A. A. (1984) · Journal of Virology · doi:10.1128/jvi.52.3.816-821.1984 · Cited by 192
Moore, A., McCarthy, L., & Mills, K. H. G. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00062-6 · Cited by 121
Epidemiology of Sexually Transmitted Diseases
Holmes, K. K., Bell, T. A., & Berger, R. E. (1984) · Urologic Clinics of North America · doi:10.1016/s0094-0143(21)00741-2 · Cited by 119
Sex differences in susceptibility to viral infection of the central nervous system
Barna, M., Komatsu, T., Bi, Z., & Reiss, C. S. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(96)00022-7 · Cited by 98
Patel, R., Tyring, S. K., Strand, A., et al. (1999) · Sexually Transmitted Infections · doi:10.1136/sti.75.6.398 · Cited by 97
Self-citationA prospective study of the psychological impact on patients with a first episode of genital herpes.
Carney, O., Ross, E. M., Bunker, C. B., Ikkos, G., & Mindel, A. (1994) · Sexually Transmitted Infections · doi:10.1136/sti.70.1.40 · Cited by 91
Self-citationGender-Dependent IL-12 Secretion by APC Is Regulated by IL-10
Wilcoxen, S. C., Kirkman, E. L., Dowdell, K., & Stohlman, S. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6237 · Cited by 89
Gender Influences Herpes Simplex Virus Type 1 Infection in Normal and Gamma Interferon-Mutant Mice
Han, X., Lundberg, P. S., Tanamachi, B., Openshaw, H., Longmate, J., & Cantin, E. M. (2001) · Journal of Virology · doi:10.1128/jvi.75.6.3048-3052.2001 · Cited by 88
Kim, S., & Voskuhl, R. R. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5561 · Cited by 77
Detection and direct typing of herpes simplex virus by polymerase chain reaction
Kimura, H., Shibata, M., Kuzushima, K., Nishikawa, K., Nishiyama, Y., & Morishima, T. (1990) · Medical Microbiology and Immunology · doi:10.1007/bf00195248 · Cited by 72
A prophylactic hepatitis B vaccine with a novel adjuvant system
Thoelen, S., Clercq, N. D., & Tornieporth, N. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00462-x · Cited by 71
Psychological and psychosexual implications of herpes simplex virus infections.
Mindel, A. (1996) · PubMed · Cited by 70
Self-citationSköldenberg, B., Jeansson, S. L., & Wolontis, S. (1975) · Scandinavian Journal of Infectious Diseases · doi:10.3109/inf.1975.7.issue-4.01 · Cited by 59
The Holy Grail: immune control of human herpes simplex virus infection and disease.
Cunningham, A. L., & Mikloška, Z. (2001) · PubMed · Cited by 59
Self-citationSingh, M., Carlson, J. R., Briones, M., Ugozzoli, M., Kazzaz, J., Barackman, J., Ott, G., & O'Hagan, D. T. (1998) · Vaccine · doi:10.1016/s0264-410x(98)00179-0 · Cited by 47
af Geijersstam, V., Wang, Z., Lewensohn‐Fuchs, I., Eklund, C., Schiller, J. T., Forsgren, M., & Dillner, J. (1998) · International Journal of Cancer · Cited by 43
Cited by
Harper, D. M., Franco, E. L., Wheeler, C., Ferris, D. G., Jenkins, D., Schuind, A., Zahaf, T., Innis, B., Naud, P., De Carvalho, N. S., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17398-4 · Cited by 1,643
Self-citationImpact of sex and gender on COVID-19 outcomes in Europe
Gebhard, C., Regitz-Zagrosek, V., Neuhauser, H. K., Morgan, R., & Klein, S. L. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00304-9 · Cited by 1,306
The X-files in immunity: sex-based differences predispose immune responses
Fish, E. N. (2008) · Nature Reviews Immunology · doi:10.1038/nri2394 · Cited by 1,162
Trends in Herpes Simplex Virus Type 1 and Type 2 Seroprevalence in the United States
Xu, F., Sternberg, M. R., Kottiri, B. J., McQuillan, G. M., Lee, F. K., Nahmias, A. J., Berman, S. M., & Markowitz, L. E. (2006) · JAMA · doi:10.1001/jama.296.8.964 · Cited by 1,035
The rgp120 HIV Vaccine Study Group (2005) · The Journal of Infectious Diseases · doi:10.1086/428404 · Cited by 952
Metadata
- Authors
- Stanberry, L. R., Spruance, S. L., Cunningham, A. L., Bernstein, D. I., Mindel, A., Sacks, S., Tyring, S., Aoki, F. Y., Slaoui, M., Denis, M., Vandepapeliere, P., & Dubin, G.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-11-21
- Volume
- 347
- Issue
- 21
- Pages
- 1652-1661
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2019840235
- Cited by
- 794
- References
- 26
- FWCI
- 35.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.